Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.83 USD | -1.70% | +18.02% | -37.36% |
Apr. 12 | Vaccinex, Inc. announced that it has received $1.75 million in funding | CI |
Apr. 02 | Vaccinex, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration- Stock Market
- Equities
- VCNX Stock
- News VACCINEXPAR
- Vaccinex Reports Positive Interim Data From Study of Pepinemab, Keytruda Combination to Treat Head, Neck Cancer